US PHARMA LAB, LLC – Trademark Portfolio

Entity Type: 16

US PHARMA LAB, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include USPL, N-CAP+, CHEWLET, HERB 360, and BOSWIHERB. The owner is based in NORTH BRUNSWICK, NJ.

1300 AIRPORT ROAD

NORTH BRUNSWICK, NJ 08902

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

US PHARMA LAB, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does US PHARMA LAB, LLC have?

US PHARMA LAB, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 10 registered, 4 abandoned, 1 cancelled.

What trademark classes does US PHARMA LAB, LLC file in?

US PHARMA LAB, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are US PHARMA LAB, LLC's most well-known trademarks?

US PHARMA LAB, LLC's registered trademark portfolio includes well-known marks such as USPL, N-CAP+, CHEWLET, HERB 360, and BOSWIHERB. These are among 10 currently registered trademarks in the portfolio.

What is US PHARMA LAB, LLC's trademark registration success rate?

US PHARMA LAB, LLC has a 67% trademark registration rate, with 10 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.